Tomas Ø. Jensen

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

Thomas L Holland, Adit A. Ginde, Roger Paredes et al. · The Lancet Respiratory Medicine · 2022 · 124 citations · Full text

Covid-19 Pandemic, Antiviral Therapy, Clinical Trials +3

Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study

Thomas Benfield, Jacob Bodilsen, Christian Brieghel et al. · Clinical Infectious Diseases · 2021 · 93 citations · Full text

Silent hypoxia in patients with SARS CoV-2 infection before hospital discharge

Natascha Josephine Ulstrand Fuglebjerg, Tomas Ø. Jensen, Nils Hoyer et al. · International Journal of Infectious Diseases · 2020 · 76 citations · Full text

Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study

Ole S. Søgaard, Joanne Reekie, Işık Somuncu Johansen et al. · Clinical Microbiology and Infection · 2022 · 64 citations · Full text

Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity

Lisa Loksø Dietz, Anna Karina Juhl, Ole S. Søgaard et al. · Communications Medicine · 2023 · 60 citations · Full text